Before a drug candidate can enter clinical trials, it undergoes preclinical testing. This phase involves laboratory studies and animal testing to evaluate the drug's safety, pharmacokinetics, and pharmacodynamics. Data from these studies help determine the starting dose for human trials and identify any potential toxicities.
